Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease

Ziqi Liu, Rong Wang(Capital Medical University), Zhe Yi(Peking University), Yuan Li(Shanxi University), Ran Duan(Peking University), Shihao He(Capital Medical University), Chu Xiao(Peking University), Zongsheng Xu(Peking University)
BMC Neurology
August 15, 2020
10.1186/s12883-020-01876-0
Cited by 30

Related Papers

Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study
|New England Journal of Medicine|2015|241
Health risk in children to fluoride exposure in a typical endemic fluorosis area on Loess Plateau, north China, in the last decade
|Chemosphere|2019|77
Characteristics of cognitive impairment in adult asymptomatic moyamoya disease
|BMC Neurology|2020|39
Increased health threats from land use change caused by anthropogenic activity in an endemic fluorosis and arsenicosis area
|Environmental Pollution|2020|30
Upregulated Cytoskeletal Proteins Promote Pathological Angiogenesis in Moyamoya Disease
|Stroke|2023|30